Teva enters pact with Klinge Biopharma, Formycon to commercialize FYB203
Teva (TEVA) announced that it has entered into a strategic collaboration with Klinge Biopharma and Formycon for the semi-exclusive ...
Business Wire2d
Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases
Gilead Sciences, Inc. (Nasdaq: GILD) and LEO Pharma today announced a strategic partnership to accelerate the development and commercialization of LEO ...
Business Insider3d
Royalty Pharma announces two steps to increase shareholder value
Royalty Pharma (RPRX) announced two major steps to enhance shareholder value. First, the Board of Directors has agreed to acquire its external manager, RP Management. This transaction to simplify ...
Stockhouse4d
FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025
HERZLIYA, Israel and CALGARY, Alberta, Jan. 9, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and ...
Finanznachrichten3d
Innocan Pharma Corporation: FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025
HERZLIYA, Israel and CALGARY, Alberta, Jan. 9, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a ...
pharmaphorum1d
A history of the pharmaceutical industry
The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...
Yahoo Finance2d
Aurinia Pharmaceuticals Inc. (AUPH)
Over the last 7 days, the United States market has remained flat, yet it is up 30% over the past year with earnings forecasted to grow by 15% annually. In this context of robust growth potential ...
Wall Street Journal3d
Eagle Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Yahoo Finance2d
Catalyst Pharmaceuticals, Inc. (CPRX)
Catalyst (CPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
pharmaphorum1d
The seven steps to selling in pharma
Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry. The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use ...
Cfr.org6d
Ensuring the Safety and Integrity of the World’s Drug, Vaccine, and Medicines Supply
Domestic U.S. drug producers, for example, now import 80 percent of their active pharmaceutical ingredients ... In March 2012, the East African Community (EAC) Medicines Registration Harmonization ...
Wall Street Journal6d
Alphabet Inc. Cl A
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...